Development of a research capacity building programme on cancer with and for Ukraine
Overview
The Horizon Europe call HORIZON-MISS-2026-02-CANCER-06 focuses on developing a research capacity building program on cancer specifically for Ukraine. It is a Coordination and Support Action (CSA) with a total budget of €5 million, expected to yield a single lump sum grant. The call emphasizes collaboration between EU Member States, Associated Countries, and Ukrainian cancer centers to enhance research and innovation capabilities in oncology.
Eligible applicants are expected to include research institutions, universities, healthcare organizations, and nonprofit entities involved in cancer research and care. The program aims to improve the integration of research with clinical practice, facilitating better patient outcomes in cancer care, particularly for children, adolescents, and young adults.
The application will follow a single-stage submission process, with the opening date scheduled for February 10, 2026, and a submission deadline of September 15, 2026. Interested organizations are encouraged to engage in joint research training, including staff exchanges and the development of digital health infrastructures like cancer registries. Co-funding is not explicitly required, though leveraging existing EU resources is encouraged.
The focus of the initiative is not just on research outputs but also on training and capacity building that would lead to improved healthcare delivery and outcomes in the context of ongoing challenges in Ukraine. The opportunity represents a highly selective and competitive funding environment, with one project expected to be funded. The call also underscores the urgent need for capacity development considering the significant cancer burden in Ukraine exacerbated by ongoing conflict.
Eligible applicants are expected to include research institutions, universities, healthcare organizations, and nonprofit entities involved in cancer research and care. The program aims to improve the integration of research with clinical practice, facilitating better patient outcomes in cancer care, particularly for children, adolescents, and young adults.
The application will follow a single-stage submission process, with the opening date scheduled for February 10, 2026, and a submission deadline of September 15, 2026. Interested organizations are encouraged to engage in joint research training, including staff exchanges and the development of digital health infrastructures like cancer registries. Co-funding is not explicitly required, though leveraging existing EU resources is encouraged.
The focus of the initiative is not just on research outputs but also on training and capacity building that would lead to improved healthcare delivery and outcomes in the context of ongoing challenges in Ukraine. The opportunity represents a highly selective and competitive funding environment, with one project expected to be funded. The call also underscores the urgent need for capacity development considering the significant cancer burden in Ukraine exacerbated by ongoing conflict.
Detail
This is a Horizon Europe call, specifically HORIZON-MISS-2026-02, aimed at supporting the implementation of the Cancer Mission. The call focuses on "Development of a research capacity building programme on cancer with and for Ukraine". It is a HORIZON Coordination and Support Action (HORIZON-CSA) with a HORIZON Lump Sum Grant [HORIZON-AG-LS] Model Grant Agreement. The deadline model is single-stage. The planned opening date is 10 February 2026, and the deadline is 15 September 2026, 17:00:00 Brussels time.
The expected outcome is to develop a wide capacity building programme between EU Member States/Associated Countries and Ukrainian cancer centres, to support improvement or development of research & innovation-related capacities and integration with cancer care. This should lead to researchers, clinicians, and healthcare professionals having access to improved research capacities, supporting better integration with care, and patients and citizens having access to improved screening, diagnostics, and treatments, while increasing their participation in clinical trials.
The scope includes setting up a research capacity-building programme between EU Member States/Associated Countries and Ukraine to develop or further improve research & innovation-related capacities of future or existing Cancer Infrastructures. The capacity building programme should include: Development of a joint-research training programme, including distance-learning modules and Twinning research activities, including staff-exchange for the implementation of targeted research projects and access to cutting-edge services.
The capacity building programme should cover at least the following areas: Enhanced involvement in quality scientific research, including development and implementation of clinical trials and other epidemiological studies and related training; Better integration of research and care to improve patient outcomes, with particular emphasis on cancer in children, adolescents and young adults; and Improvement of digital capacity to support primary and secondary use of patient data, including through improvement of data exchange capacities and development of cancer registries where needed.
Gender-related aspects, with respect to representation in research and career pathways and any other relevant aspects, should be duly taken into account. The research capacity-building programme should be tailored to the needs of the participating entities, reflecting health and research system specificities. The training module shall consist of balanced theoretical and practical parts, including simulations, case studies, group exercises, mutual learning exercises and on-site visits (when possible) to gather practical experience. Safety of participating staff/researchers should be prioritised. Advantage should be taken of experience gained under current and previous initiatives such as CCI4EU, Jane, Jane 2, Crane, CanSERV and others. The relevant EU research infrastructures in the life science domain and other EU initiatives should be exploited for available research services, as appropriate.
Regarding general conditions, admissibility conditions related to proposal page limit and layout are described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes and Part B of the Application Form available in the Submission System. Eligible countries are described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects, as detailed in the Horizon Europe Programme Guide. Other eligible conditions are subject to restrictions for the protection of European communication networks and are described in Annex B of the Work Programme General Annexes. Financial and operational capacity and exclusion are described in Annex C of the Work Programme General Annexes. Evaluation and award criteria, scoring, and thresholds are described in Annex D of the Work Programme General Annexes. The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12. Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual. The indicative timeline for evaluation and grant agreement is described in Annex F of the Work Programme General Annexes. Legal and financial set-up of the grants: Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025). The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5. These aspects are described in Annex G of the Work Programme General Annexes. Specific conditions are described in the specific topic of the Work Programme.
Application and evaluation forms and model grant agreement (MGA): Application form templates are available in the Submission System (Standard application form (HE CSA)). Evaluation form templates will be used with the necessary adaptations (Standard evaluation form (HE CSA)). Guidance is provided in the HE Programme Guide. Model Grant Agreements (MGA) include the Lump Sum MGA. Call-specific instructions, a detailed budget table (HE LS), and guidance on lump sums are also available.
Additional documents include: HE Main Work Programme 2026-2027 – 1. General Introduction, HE Main Work Programme 2026-2027 – 12. Missions, HE Main Work Programme 2026-2027 – 15. General Annexes, HE Programme Guide, HE Framework Programme 2021/695, HE Specific Programme Decision 2021/764, EU Financial Regulation 2024/2509, Decision authorising the use of lump sum contributions under the Horizon Europe Programme, Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment, EU Grants AGA — Annotated Model Grant Agreement, Funding & Tenders Portal Online Manual, Funding & Tenders Portal Terms and Conditions, and Funding & Tenders Portal Privacy Statement.
The budget overview for the year 2026 includes the following topics: HORIZON-MISS-2026-02-CANCER-01 - HORIZON-RIA with a budget of EUR 35,000,000, contributions ranging from EUR 8,000,000 to EUR 9,000,000, and an indicative number of 4 grants; HORIZON-MISS-2026-02-CANCER-02 - HORIZON-RIA with a budget of EUR 15,000,000, contributions around EUR 15,000,000, and an indicative number of 1 grant; HORIZON-MISS-2026-02-CANCER-03 - HORIZON-RIA with a budget of EUR 22,186,000, contributions ranging from EUR 7,000,000 to EUR 8,000,000, and an indicative number of 3 grants; HORIZON-MISS-2026-02-CANCER-04 - HORIZON-RIA with a budget of EUR 15,000,000, contributions around EUR 5,000,000, and an indicative number of 3 grants; HORIZON-MISS-2026-02-CANCER-05 - HORIZON-IA with a budget of EUR 7,000,000, contributions around EUR 7,000,000, and an indicative number of 1 grant; HORIZON-MISS-2026-02-CANCER-06 - HORIZON-CSA with a budget of EUR 5,000,000, contributions around EUR 5,000,000, and an indicative number of 1 grant; and HORIZON-MISS-2026-02-CANCER-07 - HORIZON-RIA with a budget of EUR 25,000,000, contributions ranging from EUR 5,000,000 to EUR 6,000,000, and an indicative number of 5 grants.
Partner search announcements are available, and LEARs, Account Administrators, or self-registrants can publish partner requests. The submission system is planned to be opened on the date stated on the topic header.
This funding opportunity is designed to bolster cancer research and care in Ukraine by fostering collaboration with EU Member States and Associated Countries. It aims to address the significant cancer burden in Ukraine, exacerbated by recent conflicts, by enhancing research capacities, improving digital infrastructure, and integrating research with clinical practice. The program encourages tailored training modules, staff exchanges, and the utilization of existing EU research infrastructures to improve cancer outcomes for Ukrainian citizens, particularly children and young adults. The funding mechanism is based on lump sum contributions, and proposals should demonstrate a clear plan for capacity building and integration of research with care, while also considering gender-related aspects in research and career pathways.
The expected outcome is to develop a wide capacity building programme between EU Member States/Associated Countries and Ukrainian cancer centres, to support improvement or development of research & innovation-related capacities and integration with cancer care. This should lead to researchers, clinicians, and healthcare professionals having access to improved research capacities, supporting better integration with care, and patients and citizens having access to improved screening, diagnostics, and treatments, while increasing their participation in clinical trials.
The scope includes setting up a research capacity-building programme between EU Member States/Associated Countries and Ukraine to develop or further improve research & innovation-related capacities of future or existing Cancer Infrastructures. The capacity building programme should include: Development of a joint-research training programme, including distance-learning modules and Twinning research activities, including staff-exchange for the implementation of targeted research projects and access to cutting-edge services.
The capacity building programme should cover at least the following areas: Enhanced involvement in quality scientific research, including development and implementation of clinical trials and other epidemiological studies and related training; Better integration of research and care to improve patient outcomes, with particular emphasis on cancer in children, adolescents and young adults; and Improvement of digital capacity to support primary and secondary use of patient data, including through improvement of data exchange capacities and development of cancer registries where needed.
Gender-related aspects, with respect to representation in research and career pathways and any other relevant aspects, should be duly taken into account. The research capacity-building programme should be tailored to the needs of the participating entities, reflecting health and research system specificities. The training module shall consist of balanced theoretical and practical parts, including simulations, case studies, group exercises, mutual learning exercises and on-site visits (when possible) to gather practical experience. Safety of participating staff/researchers should be prioritised. Advantage should be taken of experience gained under current and previous initiatives such as CCI4EU, Jane, Jane 2, Crane, CanSERV and others. The relevant EU research infrastructures in the life science domain and other EU initiatives should be exploited for available research services, as appropriate.
Regarding general conditions, admissibility conditions related to proposal page limit and layout are described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes and Part B of the Application Form available in the Submission System. Eligible countries are described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects, as detailed in the Horizon Europe Programme Guide. Other eligible conditions are subject to restrictions for the protection of European communication networks and are described in Annex B of the Work Programme General Annexes. Financial and operational capacity and exclusion are described in Annex C of the Work Programme General Annexes. Evaluation and award criteria, scoring, and thresholds are described in Annex D of the Work Programme General Annexes. The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12. Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual. The indicative timeline for evaluation and grant agreement is described in Annex F of the Work Programme General Annexes. Legal and financial set-up of the grants: Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025). The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5. These aspects are described in Annex G of the Work Programme General Annexes. Specific conditions are described in the specific topic of the Work Programme.
Application and evaluation forms and model grant agreement (MGA): Application form templates are available in the Submission System (Standard application form (HE CSA)). Evaluation form templates will be used with the necessary adaptations (Standard evaluation form (HE CSA)). Guidance is provided in the HE Programme Guide. Model Grant Agreements (MGA) include the Lump Sum MGA. Call-specific instructions, a detailed budget table (HE LS), and guidance on lump sums are also available.
Additional documents include: HE Main Work Programme 2026-2027 – 1. General Introduction, HE Main Work Programme 2026-2027 – 12. Missions, HE Main Work Programme 2026-2027 – 15. General Annexes, HE Programme Guide, HE Framework Programme 2021/695, HE Specific Programme Decision 2021/764, EU Financial Regulation 2024/2509, Decision authorising the use of lump sum contributions under the Horizon Europe Programme, Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment, EU Grants AGA — Annotated Model Grant Agreement, Funding & Tenders Portal Online Manual, Funding & Tenders Portal Terms and Conditions, and Funding & Tenders Portal Privacy Statement.
The budget overview for the year 2026 includes the following topics: HORIZON-MISS-2026-02-CANCER-01 - HORIZON-RIA with a budget of EUR 35,000,000, contributions ranging from EUR 8,000,000 to EUR 9,000,000, and an indicative number of 4 grants; HORIZON-MISS-2026-02-CANCER-02 - HORIZON-RIA with a budget of EUR 15,000,000, contributions around EUR 15,000,000, and an indicative number of 1 grant; HORIZON-MISS-2026-02-CANCER-03 - HORIZON-RIA with a budget of EUR 22,186,000, contributions ranging from EUR 7,000,000 to EUR 8,000,000, and an indicative number of 3 grants; HORIZON-MISS-2026-02-CANCER-04 - HORIZON-RIA with a budget of EUR 15,000,000, contributions around EUR 5,000,000, and an indicative number of 3 grants; HORIZON-MISS-2026-02-CANCER-05 - HORIZON-IA with a budget of EUR 7,000,000, contributions around EUR 7,000,000, and an indicative number of 1 grant; HORIZON-MISS-2026-02-CANCER-06 - HORIZON-CSA with a budget of EUR 5,000,000, contributions around EUR 5,000,000, and an indicative number of 1 grant; and HORIZON-MISS-2026-02-CANCER-07 - HORIZON-RIA with a budget of EUR 25,000,000, contributions ranging from EUR 5,000,000 to EUR 6,000,000, and an indicative number of 5 grants.
Partner search announcements are available, and LEARs, Account Administrators, or self-registrants can publish partner requests. The submission system is planned to be opened on the date stated on the topic header.
This funding opportunity is designed to bolster cancer research and care in Ukraine by fostering collaboration with EU Member States and Associated Countries. It aims to address the significant cancer burden in Ukraine, exacerbated by recent conflicts, by enhancing research capacities, improving digital infrastructure, and integrating research with clinical practice. The program encourages tailored training modules, staff exchanges, and the utilization of existing EU research infrastructures to improve cancer outcomes for Ukrainian citizens, particularly children and young adults. The funding mechanism is based on lump sum contributions, and proposals should demonstrate a clear plan for capacity building and integration of research with care, while also considering gender-related aspects in research and career pathways.
Find a Consultant to Support You
Breakdown
Eligible Applicant Types: The eligible applicant types are not explicitly stated, but the call is open to entities from EU Member States and Associated Countries. Given the focus on research capacity building, eligible applicants likely include universities, research institutes, cancer centers, healthcare organizations, and other entities with a role in cancer research and care. Public-private partnerships and NGOs could also be eligible.
Funding Type: The primary financial mechanism is a grant, specifically a HORIZON Lump Sum Grant. The call includes HORIZON Research and Innovation Actions (RIA), HORIZON Innovation Actions (IA), and HORIZON Coordination and Support Actions (CSA).
Consortium Requirement: The information does not explicitly state whether a single applicant or a consortium is required. However, the emphasis on twinning research activities and staff exchange suggests that a consortium of multiple applicants, including those from EU Member States/Associated Countries and Ukrainian cancer centers, is strongly encouraged, if not required.
Beneficiary Scope (Geographic Eligibility): The geographic eligibility includes EU Member States, Horizon Europe Associated Countries, and Ukraine. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.
Target Sector: The primary target sector is health, specifically cancer research and care. The program also touches on ICT through the improvement of digital capacity for data management and exchange, and education/training through the research capacity-building program.
Mentioned Countries: Ukraine, EU Member States, and Horizon Europe Associated Countries are mentioned.
Project Stage: The project stage is primarily focused on development and improvement of research and innovation-related capacities, integration of research with cancer care, and enhancement of digital infrastructure. This suggests a focus on development, validation, and demonstration stages, with an eye towards eventual implementation and scale-up.
Funding Amount: The funding amounts vary by topic, ranging from €5,000,000 to €35,000,000 in total budget, with individual contributions ranging from around €5,000,000 to around €15,000,000.
HORIZON-MISS-2026-02-CANCER-01 - HORIZON-RIA: €35,000,000 (Contributions: €8,000,000 to €9,000,000)
HORIZON-MISS-2026-02-CANCER-02 - HORIZON-RIA: €15,000,000 (Contributions: around €15,000,000)
HORIZON-MISS-2026-02-CANCER-03 - HORIZON-RIA: €22,186,000 (Contributions: €7,000,000 to €8,000,000)
HORIZON-MISS-2026-02-CANCER-04 - HORIZON-RIA: €15,000,000 (Contributions: around €5,000,000)
HORIZON-MISS-2026-02-CANCER-05 - HORIZON-IA: €7,000,000 (Contributions: around €7,000,000)
HORIZON-MISS-2026-02-CANCER-06 - HORIZON-CSA: €5,000,000 (Contributions: around €5,000,000)
HORIZON-MISS-2026-02-CANCER-07 - HORIZON-RIA: €25,000,000 (Contributions: €5,000,000 to €6,000,000)
Application Type: The application type is an open call with a single-stage submission process.
Nature of Support: Beneficiaries will receive money in the form of lump sum grants to support their projects.
Application Stages: The application process is single-stage.
Success Rates: The indicative number of grants varies by topic, ranging from 1 to 5. This information, combined with the total budget and contribution amounts, can provide a rough estimate of the potential success rate, though the actual rate will depend on the number of applications received.
HORIZON-MISS-2026-02-CANCER-01 - HORIZON-RIA: 4 grants
HORIZON-MISS-2026-02-CANCER-02 - HORIZON-RIA: 1 grant
HORIZON-MISS-2026-02-CANCER-03 - HORIZON-RIA: 3 grants
HORIZON-MISS-2026-02-CANCER-04 - HORIZON-RIA: 3 grants
HORIZON-MISS-2026-02-CANCER-05 - HORIZON-IA: 1 grant
HORIZON-MISS-2026-02-CANCER-06 - HORIZON-CSA: 1 grant
HORIZON-MISS-2026-02-CANCER-07 - HORIZON-RIA: 5 grants
Co-funding Requirement: The information does not explicitly state whether co-funding is required. However, as a Horizon Europe action, co-funding may be encouraged or required depending on the specific call conditions.
This Horizon Europe call, under the Cancer Mission, aims to bolster cancer research and care capacities in Ukraine through collaborative projects with EU Member States and Associated Countries. Recognizing the significant cancer burden in Ukraine, exacerbated by ongoing conflict, the call seeks to establish a research capacity-building program. This program will focus on joint research training, twinning activities like staff exchanges, and enhancing digital infrastructure for data management and cancer registries. The program intends to enhance involvement in quality scientific research, improve the integration of research and care, with a particular emphasis on cancer in children, adolescents and young adults. Projects should be tailored to the specific needs of participating entities, incorporating balanced theoretical and practical training modules. The call encourages leveraging existing EU research infrastructures and initiatives. The funding is provided as lump sum grants, and the application process is single-stage. The call is open to entities from EU Member States and Associated Countries, with a strong emphasis on collaboration with Ukrainian cancer centers. The indicative budget and number of grants vary by topic, offering a range of opportunities for different types of projects.
Funding Type: The primary financial mechanism is a grant, specifically a HORIZON Lump Sum Grant. The call includes HORIZON Research and Innovation Actions (RIA), HORIZON Innovation Actions (IA), and HORIZON Coordination and Support Actions (CSA).
Consortium Requirement: The information does not explicitly state whether a single applicant or a consortium is required. However, the emphasis on twinning research activities and staff exchange suggests that a consortium of multiple applicants, including those from EU Member States/Associated Countries and Ukrainian cancer centers, is strongly encouraged, if not required.
Beneficiary Scope (Geographic Eligibility): The geographic eligibility includes EU Member States, Horizon Europe Associated Countries, and Ukraine. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.
Target Sector: The primary target sector is health, specifically cancer research and care. The program also touches on ICT through the improvement of digital capacity for data management and exchange, and education/training through the research capacity-building program.
Mentioned Countries: Ukraine, EU Member States, and Horizon Europe Associated Countries are mentioned.
Project Stage: The project stage is primarily focused on development and improvement of research and innovation-related capacities, integration of research with cancer care, and enhancement of digital infrastructure. This suggests a focus on development, validation, and demonstration stages, with an eye towards eventual implementation and scale-up.
Funding Amount: The funding amounts vary by topic, ranging from €5,000,000 to €35,000,000 in total budget, with individual contributions ranging from around €5,000,000 to around €15,000,000.
HORIZON-MISS-2026-02-CANCER-01 - HORIZON-RIA: €35,000,000 (Contributions: €8,000,000 to €9,000,000)
HORIZON-MISS-2026-02-CANCER-02 - HORIZON-RIA: €15,000,000 (Contributions: around €15,000,000)
HORIZON-MISS-2026-02-CANCER-03 - HORIZON-RIA: €22,186,000 (Contributions: €7,000,000 to €8,000,000)
HORIZON-MISS-2026-02-CANCER-04 - HORIZON-RIA: €15,000,000 (Contributions: around €5,000,000)
HORIZON-MISS-2026-02-CANCER-05 - HORIZON-IA: €7,000,000 (Contributions: around €7,000,000)
HORIZON-MISS-2026-02-CANCER-06 - HORIZON-CSA: €5,000,000 (Contributions: around €5,000,000)
HORIZON-MISS-2026-02-CANCER-07 - HORIZON-RIA: €25,000,000 (Contributions: €5,000,000 to €6,000,000)
Application Type: The application type is an open call with a single-stage submission process.
Nature of Support: Beneficiaries will receive money in the form of lump sum grants to support their projects.
Application Stages: The application process is single-stage.
Success Rates: The indicative number of grants varies by topic, ranging from 1 to 5. This information, combined with the total budget and contribution amounts, can provide a rough estimate of the potential success rate, though the actual rate will depend on the number of applications received.
HORIZON-MISS-2026-02-CANCER-01 - HORIZON-RIA: 4 grants
HORIZON-MISS-2026-02-CANCER-02 - HORIZON-RIA: 1 grant
HORIZON-MISS-2026-02-CANCER-03 - HORIZON-RIA: 3 grants
HORIZON-MISS-2026-02-CANCER-04 - HORIZON-RIA: 3 grants
HORIZON-MISS-2026-02-CANCER-05 - HORIZON-IA: 1 grant
HORIZON-MISS-2026-02-CANCER-06 - HORIZON-CSA: 1 grant
HORIZON-MISS-2026-02-CANCER-07 - HORIZON-RIA: 5 grants
Co-funding Requirement: The information does not explicitly state whether co-funding is required. However, as a Horizon Europe action, co-funding may be encouraged or required depending on the specific call conditions.
This Horizon Europe call, under the Cancer Mission, aims to bolster cancer research and care capacities in Ukraine through collaborative projects with EU Member States and Associated Countries. Recognizing the significant cancer burden in Ukraine, exacerbated by ongoing conflict, the call seeks to establish a research capacity-building program. This program will focus on joint research training, twinning activities like staff exchanges, and enhancing digital infrastructure for data management and cancer registries. The program intends to enhance involvement in quality scientific research, improve the integration of research and care, with a particular emphasis on cancer in children, adolescents and young adults. Projects should be tailored to the specific needs of participating entities, incorporating balanced theoretical and practical training modules. The call encourages leveraging existing EU research infrastructures and initiatives. The funding is provided as lump sum grants, and the application process is single-stage. The call is open to entities from EU Member States and Associated Countries, with a strong emphasis on collaboration with Ukrainian cancer centers. The indicative budget and number of grants vary by topic, offering a range of opportunities for different types of projects.
Short Summary
Impact Develop a research capacity building programme on cancer with and for Ukraine to enhance research and clinical trial capabilities, improve integration of research with care, and support better patient outcomes. | Impact | Develop a research capacity building programme on cancer with and for Ukraine to enhance research and clinical trial capabilities, improve integration of research with care, and support better patient outcomes. |
Applicant Applicants should possess expertise in cancer research, healthcare, and capacity building, with the ability to establish collaborative partnerships between EU Member States and Ukrainian institutions. | Applicant | Applicants should possess expertise in cancer research, healthcare, and capacity building, with the ability to establish collaborative partnerships between EU Member States and Ukrainian institutions. |
Developments Funding will support the establishment of a comprehensive capacity-building programme focused on cancer research and care, including joint research training and staff exchange activities. | Developments | Funding will support the establishment of a comprehensive capacity-building programme focused on cancer research and care, including joint research training and staff exchange activities. |
Applicant Type This funding is designed for research institutions, universities, cancer centers, healthcare organizations, and other entities involved in cancer research and care from EU Member States and Associated Countries, particularly those collaborating with Ukrainian counterparts. | Applicant Type | This funding is designed for research institutions, universities, cancer centers, healthcare organizations, and other entities involved in cancer research and care from EU Member States and Associated Countries, particularly those collaborating with Ukrainian counterparts. |
Consortium A consortium of multiple applicants is required, emphasizing collaboration between EU Member States/Associated Countries and Ukrainian cancer centers. | Consortium | A consortium of multiple applicants is required, emphasizing collaboration between EU Member States/Associated Countries and Ukrainian cancer centers. |
Funding Amount The total budget for this funding opportunity is €5,000,000, with an expected EU contribution of approximately €5,000,000 per project. | Funding Amount | The total budget for this funding opportunity is €5,000,000, with an expected EU contribution of approximately €5,000,000 per project. |
Countries Ukraine is explicitly mentioned as a primary beneficiary, along with EU Member States and Associated Countries involved in the project. | Countries | Ukraine is explicitly mentioned as a primary beneficiary, along with EU Member States and Associated Countries involved in the project. |
Industry This funding targets the health sector, specifically cancer research and capacity building. | Industry | This funding targets the health sector, specifically cancer research and capacity building. |
Update Log
No updates recorded yet.
Discover with AI
Let our intelligent agent help you find the perfect funding opportunities tailored to your needs.
Try AI Agent →
EU Grant Database
Explore European funding opportunities in our comprehensive, up-to-date collection.
Browse Database →
Stay Informed
Get notified when grants change, deadlines approach, or new opportunities match your interests.
Configure Notifications →
Track Your Favorites
Follow grants you're interested in and keep them organized in one place. Get updates on changes and deadlines.
Use the Follow button above ↑
Research infrastructures as accelerators of the integration of Ukraine in the European Research Area
Call for ProposalForthcoming
This summary outlines the Horizon Europe call titled "Research infrastructures as accelerators of the integration of Ukraine in the European Research Area," specifically identified as...
June 16th, 2026
Improve the Quality of Life of older cancer patients
Call for ProposalForthcoming
The Horizon Europe call HORIZON-MISS-2026-02-CANCER-07 aims to enhance the quality of life for older cancer patients aged 65 and above. Scheduled to open on February 10, 2026, and closing on...
September 15th, 2026
Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers
Call for ProposalForthcoming
The EU funding opportunity HORIZON-MISS-2026-02-CANCER-03 is part of the Horizon Europe program, specifically targeting the optimization of immunotherapeutic interventions for patients with...
September 15th, 2026
Earlier and more precise palliative care
Call for ProposalForthcoming
The HORIZON-MISS-2026-02-CANCER-04 is a funding opportunity under Horizon Europe, focusing on improving earlier and more precise palliative care for cancer patients. This call aims to enhance the...
September 15th, 2026
Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
Call for ProposalForthcoming
The grant opportunity titled "Boosting Mental Health of Young Cancer Survivors through the European Cancer Patient Digital Centre (ECPDC)" falls under the Horizon Europe initiative, specifically...
September 15th, 2026
Call for proposals to pilot and implement cancer screening programmes for lung cancer
Call for ProposalOpen
The EU4Health Programme has announced a funding opportunity under the identifier EU4H-2026-SANTE-PJ-02 for piloting and implementing cancer screening programs for lung cancer. The total budget for...
January 6th, 2026
Call for proposals to pilot and implement cancer screening programmes for prostate cancer
Call for ProposalOpen
This document outlines a significant opportunity for funding through the EU4Health Programme, specifically targeting cancer screening initiatives for prostate cancer within the call titled...
January 6th, 2026
Enabling user-centred and open innovation initiatives to enhance soil health in Ukraine
Call for ProposalForthcoming
The grant opportunity titled HORIZON-MISS-2026-05-SOIL-03 is designed to enhance soil health in Ukraine through user-centered and open innovation initiatives. This initiative falls under the HORIZON...
September 23rd, 2026
Strengthening forest research for the support of Ukraine
Call for ProposalForthcoming
The grant opportunity HORIZON-CL6-2027-01-CIRCBIO-10 aims to strengthen forest research to support the recovery, resilience, and EU integration of Ukraine's forest sector following the impacts of...
September 22nd, 2027
Deployment of cutting-edge multi-modal AI-based solutions in medical imaging
Call for ProposalOpen
The EU grant opportunity titled "Deployment of cutting-edge multi-modal AI-based solutions in medical imaging" is part of the Digital Europe Programme under the call DIGITAL-2026-AI-09. It aims to...
March 3rd, 2026
Call for proposals to pilot and implement cancer screening programmes for gastric cancer
Call for ProposalOpen
The EU4Health Programme has initiated a call for proposals to pilot and implement cancer screening programs specifically for gastric cancer, identified as EU4H-2026-SANTE-PJ-01. The funding...
January 6th, 2026
Scaling up innovation in cardiovascular health
Call for ProposalForthcoming
The HORIZON-HLTH-2026-01-DISEASE-15 grant opportunity focuses on "Scaling up Innovation in Cardiovascular Health" and is part of the Horizon Europe programme. It involves a Coordination and Support...
April 16th, 2026